The smoldering myeloid leukemic states: clinical and biologic features.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001792:Blood Platelets / Q000648:ultrastructure; D001856:Bone Marrow Examination; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002999:Clone Cells; D004912:Erythrocytes / Q000648:ultrastructure; D006801:Humans; D007951:Leukemia, Myeloid / Q000097:blood / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D009504:Neutrophils / Q000648:ultrastructure; D011289:Preleukemia / Q000097:blood / Q000473:pathology* / Q000503:physiopathology; D011379:Prognosis
D000970:Antineoplastic Agents